Guiding the Advancement of Pediatric Clinical Trials
ACT for Children’s Advisory Committee provides strategic advice, guidance in alignment with our mission and expert resources to help advance and accelerate pediatric clinical trials.
External Advisory Committee
The advisory committee regularly reviews I-ACT for Children’s project portfolio and advises the Institute’s management team regarding the alignment of the portfolio with the organization’s mission and values. The Committee assists the Institute’s management team in identifying highest priority needs of children related to product development and to innovations that are likely to have the greatest impact on this development.
2023 External Advisory Committee Members
John S. Bradley, M.D.
Medical Director, Division of Infectious Diseases, Rady Children’s Hospital-San Diego Distinguished Professor, University of California San Diego School of Medicine
Jonathan M. Davis, M.D.
Vice-Chair of Pediatrics and Chief of Newborn Medicine, Tufts Children’s Hospital Professor of Pediatrics, Tufts University School of Medicine
Kathleen A. Neville, M.D., M.S., MBA, FAAP, FCCP
Senior Director, Janssen Pharmaceutical Companies of Johnson & Johnson
William E. Smoyer, M.D., FASN
C. Robert Kidder Chair
Vice President, Clinical and Translational Research
C. Robert Kidder Chair Vice President, Clinical and Translational Research, Research Institute, Nationwide Children’s Hospital Director, Nationwide Children’s Hospital Center for Clinical and Translational Research Professor of Pediatrics, The Ohio State University
Pediatric Expert Panels
I-ACT for Children facilitates expert panels to advise on projects in the following areas:
Hari Cheryl Sachs, MD
FDA Pediatrician 2002-2020
FDA Pediatric Team Leader 2007-2020
Andrew E. Mulberg, MD
Pediatric Gastroenterologist and Pharmaceutical Industry Executive
FDA Deputy Director, Division of Gastroenterology and Inborn Error Products 2010-2016
Stephen P. Spielberg, MD, PhD
Expert in Pharmacogenomics, Drug Development, Personalized Medicine, Pediatric Pharmacology
FDA Deputy Commissioner for Medicinal Products and Tobacco 2011-2013
Access Relevant Resources
Cell and Gene Therapy
Tamera Coyne-Beasley, MD, MPH
Derroll M. Dawkins, MD Endowed Chair in Adolescent Medicine
Professor of Pediatrics & Internal Medicine at the University of Alabama, Birmingham
Jamie Fergie, MD
Director of Pediatric Infectious Diseases at Driscoll Children’s Hospital
Professor of Pediatrics at Texas A&M University College of Medicine
Medical Director of the Global Institute for Hispanic Health
Robert Nobles, DrPH, MPH
Vice President for Research Administration at Emory University
Find out how I-ACT for Children can help advance your pediatric development project.